Is Zepp Health Stock a Good Investment?
Zepp Health Investment Advice | ZEPP |
- Examine Zepp Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zepp Health's leadership team and their track record. Good management can help Zepp Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Electronic Equipment, Instruments & Components space and any emerging trends that could impact Zepp Health's business and its evolving consumer preferences.
- Compare Zepp Health's performance and market position to its competitors. Analyze how Zepp Health is positioned in terms of product offerings, innovation, and market share.
- Check if Zepp Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zepp Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zepp Health Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zepp Health Corp is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Weakest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Zepp Health Stock
Researching Zepp Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 33.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.52. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zepp Health Corp recorded a loss per share of 4.0. The entity last dividend was issued on the 25th of March 2022. The firm had 1:4 split on the 16th of September 2024.
To determine if Zepp Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zepp Health's research are outlined below:
| Zepp Health Corp generated a negative expected return over the last 90 days | |
| Zepp Health Corp has high historical volatility and very poor performance | |
| Zepp Health Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.33 B. Net Loss for the year was (75.81 M) with profit before overhead, payroll, taxes, and interest of 86.7 M. | |
| Zepp Health Corp currently holds about 996.59 M in cash with (24.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.22. | |
| Latest headline from news.google.com: Will Zepp Health Corporation Depositary Receipt stock attract ESG investors - July 2025 Price Swings Fast Entry Momentum Trade Alerts - newser.com |
Zepp Health Quarterly Cash And Short Term Investments |
|
Zepp Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zepp Health Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zepp Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Zepp Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Zepp Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-08-18 | 2020-06-30 | 0.35 | 0.3 | -0.05 | 14 | ||
2018-11-26 | 2018-09-30 | 0.39 | 0.45 | 0.06 | 15 | ||
2023-11-20 | 2023-09-30 | 0.23 | 0.05 | -0.18 | 78 | ||
2023-03-21 | 2022-12-31 | 0.04 | -0.14 | -0.18 | 450 | ||
2024-05-20 | 2024-03-31 | -0.03 | -0.2263 | -0.1963 | 654 | ||
2024-08-21 | 2024-06-30 | 0.04 | -0.1665 | -0.2065 | 516 | ||
2022-08-25 | 2022-06-30 | -1.32 | -1.54 | -0.22 | 16 | ||
2024-03-18 | 2023-12-31 | 0.3 | 0.06 | -0.24 | 80 |
Zepp Health Target Price Consensus
Zepp target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Zepp Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most Zepp analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Zepp stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Zepp Health Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationZepp Health Target Price Projection
Zepp Health's current and average target prices are 23.99 and 64.37, respectively. The current price of Zepp Health is the price at which Zepp Health Corp is currently trading. On the other hand, Zepp Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Zepp Health Market Quote on 17th of November 2025
Target Price
Analyst Consensus On Zepp Health Target Price
Zepp Health Analyst Ratings
Zepp Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Zepp Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Zepp Health's financials, market performance, and future outlook by experienced professionals. Zepp Health's historical ratings below, therefore, can serve as a valuable tool for investors.Know Zepp Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zepp Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zepp Health Corp backward and forwards among themselves. Zepp Health's institutional investor refers to the entity that pools money to purchase Zepp Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rialto Wealth Management, Llc | 2025-06-30 | 1000 | Sbi Securities Co Ltd | 2025-06-30 | 726 | Rhumbline Advisers | 2025-06-30 | 493 | Jpmorgan Chase & Co | 2025-06-30 | 231 | Citigroup Inc | 2025-06-30 | 173 | Lazard Asset Management Llc | 2025-06-30 | 157 | Bank Of America Corp | 2025-06-30 | 62.0 | Mccormack Advisors International | 2025-06-30 | 53.0 | Acadian Asset Management Llc | 2025-06-30 | 0.0 | Fidelity International Ltd | 2025-06-30 | 704.3 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 609.8 K |
Zepp Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 362.08 M.Market Cap |
|
Zepp Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.15) | (0.14) | |
| Return On Capital Employed | (0.14) | (0.13) | |
| Return On Assets | (0.14) | (0.14) | |
| Return On Equity | (0.30) | (0.29) |
Determining Zepp Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Zepp Health is a good buy. For example, gross profit margin measures Zepp Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zepp Health's profitability and make more informed investment decisions.
Evaluate Zepp Health's management efficiency
Zepp Health Corp has return on total asset (ROA) of (0.0365) % which means that it has lost $0.0365 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2436) %, meaning that it created substantial loss on money invested by shareholders. Zepp Health's management efficiency ratios could be used to measure how well Zepp Health manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/17/2025, Return On Tangible Assets is likely to grow to -0.14. In addition to that, Return On Capital Employed is likely to grow to -0.13. At this time, Zepp Health's Total Current Liabilities is relatively stable compared to the past year. As of 11/17/2025, Liabilities And Stockholders Equity is likely to grow to about 4.1 B, while Non Current Liabilities Total is likely to drop slightly above 466.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 456.02 | 380.17 | |
| Tangible Book Value Per Share | 425.94 | 358.97 | |
| Enterprise Value Over EBITDA | (1.73) | (1.64) | |
| Price Book Value Ratio | 0.04 | 0.04 | |
| Enterprise Value Multiple | (1.73) | (1.64) | |
| Price Fair Value | 0.04 | 0.04 | |
| Enterprise Value | 597.9 M | 420 M |
Effective leadership at Zepp Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 1.389 |
Basic technical analysis of Zepp Stock
As of the 17th of November 2025, Zepp Health maintains the Standard Deviation of 8.05, market risk adjusted performance of (0.15), and Mean Deviation of 5.56. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zepp Health Corp, as well as the relationship between them.Zepp Health's Outstanding Corporate Bonds
Zepp Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zepp Health Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zepp bonds can be classified according to their maturity, which is the date when Zepp Health Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Zepp Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Zepp Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 5.56 | |||
| Coefficient Of Variation | (3,099) | |||
| Standard Deviation | 8.05 | |||
| Variance | 64.82 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 49.14 | |||
| Value At Risk | (9.89) | |||
| Potential Upside | 12.92 | |||
| Skewness | 0.5492 | |||
| Kurtosis | 2.7 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 5.56 | |||
| Coefficient Of Variation | (3,099) | |||
| Standard Deviation | 8.05 | |||
| Variance | 64.82 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 49.14 | |||
| Value At Risk | (9.89) | |||
| Potential Upside | 12.92 | |||
| Skewness | 0.5492 | |||
| Kurtosis | 2.7 |
Consider Zepp Health's intraday indicators
Zepp Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zepp Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Zepp Health Corporate Filings
| 14th of November 2025 Other Reports | ViewVerify | |
| 12th of November 2025 Other Reports | ViewVerify | |
6K | 5th of November 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 21st of May 2025 Other Reports | ViewVerify |
Zepp Stock media impact
There is far too much social signal, news, headlines, and media speculation about Zepp Health that are available to investors today. This information is accessible both publicly - through Zepp Health's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Zepp-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Zepp Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zepp Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zepp Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zepp Health alpha.
Zepp Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Zepp Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zepp Health Maximum Pain Price Across December 19th 2025 Option Contracts
Zepp Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Zepp Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Zepp Health's options.
Zepp Health Corporate Management
| Xiaojun Zhang | VP Resources | Profile | |
| Hui Wang | Vice President of Corporate Strategy and General Manager of Beijing Operations | Profile | |
| Jimmy Lai | Independent Director | Profile | |
| Hongjiang Zhang | Independent Director | Profile | |
| De Liu | Director | Profile |
Already Invested in Zepp Health Corp?
The danger of trading Zepp Health Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zepp Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zepp Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zepp Health Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Zepp Stock Analysis
When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.